Network Meta-Analysis Validates the Use of Methotrexate in RA Compared With Other Treatments
A network meta-analysis confirmed the efficacy of methotrexate for patients with rheumatoid arthritis (RA) and validated it as the primary reference conventional synthetic disease-modifying antirheumatic drug for treatment in this population.